
Read More
Suven Life Sciences Achieves 100% Patient Enrolment for MDD Phase-2b Trial ...
The stock is up over 70 per cent from its 52-week low of Rs 102.70 per share with multibagger return...

The stock is up over 70 per cent from its 52-week low of Rs 102.70 per share with multibagger return...

The company released a press release on Monday, stating Advent International has entered into defini...

On Tuesday, the domestic equities continued the upwards journey for the second straight session as l...

At noon on Tuesday, the headline equity indices, i.e. Sensex and Nifty 50 were trading higher by a p...
Copyright 2025 by DSIJ Wealth Advisory Pvt. Ltd. (Formerly Known as DSIJ Pvt. Ltd.)